[go: up one dir, main page]

MX2016005532A - Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades. - Google Patents

Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.

Info

Publication number
MX2016005532A
MX2016005532A MX2016005532A MX2016005532A MX2016005532A MX 2016005532 A MX2016005532 A MX 2016005532A MX 2016005532 A MX2016005532 A MX 2016005532A MX 2016005532 A MX2016005532 A MX 2016005532A MX 2016005532 A MX2016005532 A MX 2016005532A
Authority
MX
Mexico
Prior art keywords
plasma state
methods
nitric oxide
diseases
medical conditions
Prior art date
Application number
MX2016005532A
Other languages
English (en)
Inventor
Michael Pohl
Howard Nelson
Alexander Dolgopolsky
Michael D Preston
Victor N Vasilets
Original Assignee
Origin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Origin Inc filed Critical Origin Inc
Publication of MX2016005532A publication Critical patent/MX2016005532A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)

Abstract

Se describen métodos para administrar óxido nítrico (NO) en un estado de plasma a un sitio de tratamiento. Una corriente discreta de materia se coloca en un estado de plasma, en el cual la corriente tiene, como parte de su contenido, una concentración deseada de NO. La corriente discreta de materia se dirige a un sitio de acción para lograr un resultado terapéutico.
MX2016005532A 2013-10-31 2014-10-30 Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades. MX2016005532A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361898390P 2013-10-31 2013-10-31
PCT/US2014/063075 WO2015066278A1 (en) 2013-10-31 2014-10-30 Methods for using nitric oxide in a plasma state to treat medical conditions and diseases

Publications (1)

Publication Number Publication Date
MX2016005532A true MX2016005532A (es) 2016-07-12

Family

ID=53005100

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005532A MX2016005532A (es) 2013-10-31 2014-10-30 Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.

Country Status (14)

Country Link
US (1) US20160193336A1 (es)
EP (2) EP3398618B8 (es)
JP (3) JP2016529231A (es)
KR (1) KR20160082680A (es)
CN (1) CN105473166A (es)
AR (1) AR098280A1 (es)
AU (1) AU2014342242A1 (es)
CA (1) CA2917170A1 (es)
IL (1) IL243668A0 (es)
MX (1) MX2016005532A (es)
RU (1) RU2016106303A (es)
TW (1) TW201521805A (es)
WO (1) WO2015066278A1 (es)
ZA (1) ZA201604187B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6376571B2 (ja) 2013-03-15 2018-08-22 ザ ジェネラル ホスピタル コーポレイション 吸入用一酸化窒素の合成
BR112015022466B1 (pt) 2013-03-15 2022-11-08 The General Hospital Corporation Método e aparelho para síntese inspiratória de óxido nítrico
AU2015274551A1 (en) * 2014-06-13 2016-12-22 Origin, Inc. Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals
JP6947633B2 (ja) 2014-10-20 2021-10-13 ザ ジェネラル ホスピタル コーポレイション 一酸化窒素の合成のためのシステム及び方法
KR102106055B1 (ko) 2015-08-10 2020-04-29 아주대학교 산학협력단 근육 손상 치료용 질소기반 저온 대기압 플라즈마
WO2017042636A1 (en) * 2015-09-09 2017-03-16 Advanced Inhalation Therapies (Ait) Ltd. Nitric oxide inhalation therapy for infants with bronchiolitis
CA3018379A1 (en) 2016-03-25 2017-09-28 The General Hospital Corporation Delivery systems and methods for electric plasma synthesis of nitric oxide
EP4234018A3 (en) * 2016-12-14 2023-11-01 Origin, Inc. A device and method for producing high-concentration, low-temperature nitric oxide
CN113456966A (zh) 2017-02-27 2021-10-01 第三极股份有限公司 用于移动生成一氧化氮的系统和方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
CN110573454B (zh) 2017-02-27 2021-08-20 第三极股份有限公司 生成一氧化氮的系统和方法
US10239038B2 (en) 2017-03-31 2019-03-26 The General Hospital Corporation Systems and methods for a cooled nitric oxide generator
US11229806B2 (en) 2017-05-08 2022-01-25 L'oreal Cold atmospheric plasma treatment with chemical or organic compounds to modify the keratinous substrate microbiota
KR102030528B1 (ko) * 2018-03-29 2019-11-08 주식회사 지씨에스 피부관리장치 및 그 장치의 구동방법
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
JP2022532654A (ja) 2019-05-15 2022-07-15 サード ポール，インコーポレイテッド 一酸化窒素を生成するシステム及び方法
US20220339373A1 (en) * 2019-07-01 2022-10-27 Universiteit Gent Plasma enhanced aerosol device
DE102019006536B3 (de) 2019-09-16 2020-12-31 Blv Licht- Und Vakuumtechnik Gmbh Vorrichtung und Verfahren zur Haut- und insbesondere Wundbehandlung unter Verwendung von Plasma
US11691879B2 (en) 2020-01-11 2023-07-04 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. SYSTEMS AND METHODS FOR PREVENTING AND TREATING INFECTIONS WITH NITRIC OXIDE
US11975139B2 (en) 2021-09-23 2024-05-07 Third Pole, Inc. Systems and methods for delivering nitric oxide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH175164A (de) * 1934-03-09 1935-02-16 Ronzi Carl Vorrichtung zur Behandlung der Haut.
US4336798A (en) * 1980-10-06 1982-06-29 Anthony V. Beran Medical corrugated respiratory tube
US5396882A (en) * 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
BR9303645A (pt) * 1993-08-31 1995-04-25 Oliveira Marques Antonio Se De Processo de fabricação de produto alimentício
WO1995022335A1 (en) * 1994-02-21 1995-08-24 Aberdeen University Acidified nitrite as an antimicrobial agent
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6758214B2 (en) * 2000-01-28 2004-07-06 Cyterra Corporation Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
US20040009238A1 (en) * 2002-07-09 2004-01-15 Chris Miller Exogenenous nitric oxide gas (gNO) therapy in wound healing
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
RU2183474C1 (ru) 2001-02-09 2002-06-20 Пекшев Александр Валерьевич Способ и устройство для формирования no-содержащего газового потока для воздействия на биологический объект
US20070065473A1 (en) * 2002-07-09 2007-03-22 Miller Christopher C Nitric oxide gas (gO) as a cosmetic and wound healing agent
KR100580737B1 (ko) * 2004-07-16 2006-05-15 주식회사 팬택앤큐리텔 다중 메시지 통합 기능을 가지는 무선통신 단말기 및 그방법
EP2160081A1 (en) * 2008-08-27 2010-03-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Non-thermal plasma for wound treatment and associated apparatus and method

Also Published As

Publication number Publication date
RU2016106303A3 (es) 2018-07-23
US20160193336A1 (en) 2016-07-07
ZA201604187B (en) 2017-09-27
KR20160082680A (ko) 2016-07-08
EP2999489A1 (en) 2016-03-30
RU2016106303A (ru) 2017-12-05
EP3398618B1 (en) 2020-12-09
JP2019142862A (ja) 2019-08-29
EP2999489A4 (en) 2017-03-08
AU2014342242A1 (en) 2016-02-04
CN105473166A (zh) 2016-04-06
TW201521805A (zh) 2015-06-16
WO2015066278A1 (en) 2015-05-07
CA2917170A1 (en) 2015-05-07
EP3398618A1 (en) 2018-11-07
IL243668A0 (en) 2016-02-29
JP2018027933A (ja) 2018-02-22
AR098280A1 (es) 2016-05-26
EP3398618B8 (en) 2021-01-20
JP2016529231A (ja) 2016-09-23

Similar Documents

Publication Publication Date Title
MX2016005532A (es) Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.
MX2016016137A (es) Metodos veterinarios para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades en animales.
MX2020004023A (es) Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia.
MX365950B (es) Compuestos de piridazinona y metodos para el tratamiento de la fibrosis quistica.
IN2015DN00450A (es)
MX2017004471A (es) Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística.
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
PH12013500618A1 (en) Therapeutic use of a tlr agonist and combination therapy
MX370953B (es) Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes.
PH12015502302B1 (en) Treatment of allergic rhinitis using a combination of mometasone and olopatadine
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
MX2015011905A (es) Uso de levocetirizina y montelukast en el tratamiento de la vasculitis.
MX2015012315A (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
MY186840A (en) Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy
SG10201908587PA (en) Treatment regimens
TW201613599A (en) Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease
EA201491836A1 (ru) Способы лечения рака с использованием ингибитора pi3k и ингибитора mek
EA201491629A1 (ru) Способы лечения рака с использованием липоплатина
UA67427U (ru) Способ лечения фиброзно-кавернозных форм органного туберкулеза
UA105429C2 (ru) Способ лечения опухолевых образований
RU2012110137A (ru) Способ лечения инсулинорезистентности
UA84693U (ru) Способ лечения больных неалкогольным стеатогепатитом в сочетании с хроническим бронхитом на фоне ожирения
NZ629711A (en) Anti-inflammatory compositions, methods and uses thereof
UA67953U (ru) Установка для лечения вирусных гепатитов с использованием медицинского озона